2010年（平成22年）
Goto Y, Koyanagi K, Narita N, Kawakami Y, Takata M, Uchiyama A, Nguyen L, Nguyen T, Morton DL, Hoon D. Aberrant Fatty Acid-Binding Protein 7 Gene Expression In Cutaneous Malignant Melanoma.J Invest Dermatol. 130(1):221-229,2010,Jan
Sumimoto H, Kawakami Y. The RNA silencing technology applied by lentiviral vectors in oncology, in “Lentivirus Gene Engineering Protocols second edition” Humana Press. :187-199,2009
Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Letters. 291(2):150-157,2010,May
Ohkusu-Tsukada K, Toda M, Udono H, Kawakami Y, Takahashi K. Targeted inhibition of IL-10-secreting CD25 Treg via p38 MAPK suppression in cancer immunotherapy. Eur. J. Immunol.40(4):1011-1021,2010,Apr
Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara T.Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402. J Transl Med.8:84,2010,Sep